# Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer

> **NCT00005050** · PHASE1,PHASE2 · COMPLETED · sponsor: **NYU Langone Health**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** ethynyluracil
- **DRUG:** fluorouracil
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00005050
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** 2001-06
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005050, "Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*